NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-200-1994-2-IN-03 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof IN National Stage 2000/00143/CHE Abandoned
NCI E-200-1994-2-CA-06 Monomeric and Dimeric Arylisoquinoline Alkaloids and Derivatives Thereof CA National Stage 2313487 Abandoned
NICHD E-010-1998-1-CA-05 The Protein Tyrosine Kinase Substrate LATand It's Use in the Identification of (Ant) Agonists of the Kinase CA National Stage 2316769 Abandoned
NCI E-151-1998-0-US-01 Water-Insoluble Drug Delivery System US 60/113,423 Abandoned
NCI E-133-1991-0-US-05 HUMAN CRIPTO-RELATED GENE US CON 09/222,246 Abandoned
NCI E-029-1999-0-PCT-02 Brefeldin a Derivatives PCT PCT PCT/US1998/027000 Expired
NCI E-068-1993-1-US-08 Methods of Assesing MHC Class I Expression and Proteins Capable of Modulation Class I Expression US DIV 09/215,989 Abandoned
NCI E-068-1993-1-US-07 Method of Assessing MHC Class I Expression and Proteins Capable of Modulation Class I Expression US DIV 09/215,712 Abandoned
NIDCR E-106-1998-0-US-01 NOVEL METHODS AND COMPOSITIONS FOR THE PREPARATION OF SILYL DERIVATIVES OF RESINS US ORD 09/213,892 6177534 Expired PDF
NCI E-002-1996-1-US-14 NUCLEIC ACID ENCODING MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS US DIV 09/215,035 6153430 Expired PDF
NINDS E-106-1995-0-US-08 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY US CON 09/212,165 6669935 Abandoned PDF
NCI E-124-1996-0-US-03 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE I (FRAG1), RELATED PROTEINS AND METHODS US National Stage 09/202,548 6323316 Expired PDF
NCI E-075-1998-0-US-01 Method for Deoxygenation of Nucleoside Secondary Alcohols US 60/112,327 Abandoned
NHLBI E-067-1996-0-US-06 ULTRASOUND-HALL EFFECT IMAGING SYSTEM AND METHOD US National Stage 09/202,459 6520911 Expired PDF
NIAID E-133-1993-0-US-12 BINDING DOMAINS FROM PLASMODIUM VIVAX AND PLASMODIUM FALCIPARUM ERYTHROCYTE BINDING PROTEINS US DIV 09/210,288 6392026 Abandoned PDF
NICHD E-070-1998-0-US-01 (DESIGNS FOR) NON-CONTACT LASER CAPTURE MICRODISSECTION US 60/111,662 Abandoned
NCI E-022-2006-1-US-02 Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor US DIV 09/209,180 Abandoned
NCI E-267-1997-0-PCT-02 METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA) PCT PCT PCT/US1998/026109 Expired
NCI E-256-1998-0-US-01 A Recombinant Vector Expressing Multiple Costimulatory Molecules and Uses Thereof US 60/111,582 Abandoned
NIDDK E-225-1995-2-US-08 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. US National Stage 09/117,598 6066642 Abandoned PDF
NINDS E-153-1991-1-US-04 DEFECTIVE,INTERFERING HIV PARTICLES US DIV 09/206,497 Abandoned
NIAID E-019-1998-0-AU-03 VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX AU National Stage 16257/99 Abandoned
NICHD E-020-1999-0-PCT-01 A VI-REPA CONJUGATE VACCINE FOR IMMUNIZATION AGAINST SALMONELLA TYPHI PCT PCT PCT/US1998/025746 Expired
NIAID E-019-1998-0-PCT-02 VACCINES FOR BLOCKING TRANSMISSION OF PLASMODIUM VIVAX PCT PCT PCT/US1998/025742 Expired
NCI E-182-1997-0-PCT-02 UREIDO DERIVATIVES OF POLY-4-AMINO-2-CARBOXY-1-METHYL PYRROLE COMPOUNDS INHIBITION OF INFLAMMATION PCT PCT PCT/US1998/025811 Expired
NIAID E-019-1998-0-EP-05 VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX EP National Stage 98960730.4 Abandoned
NIAID E-019-1998-0-BR-04 VACCINE FOR BLOCKING TRANSMISSION OF PLASMODIAM VIVAX BR National Stage PI9813408-6 Abandoned
NINDS E-232-1997-0-US-02 Single-Shot Spiral Scanning Magnetic Resonance Imaging With Trapezodial Gradients US ORD 09/203,321 Abandoned
NCI E-009-1999-0-US-01 A Novel ATP-Binding Cassette Protein Responsible for Cytotoxin Resistance US 60/110,473 Abandoned
NCI E-260-1998-0-US-01 System and Method for Representing Knowledge in a Distributed System US 09/203,037 Abandoned
NCI E-021-1998-0-CA-04 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use CA National Stage 2318576 Expired
NCI E-021-1998-0-IL-06 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use IL National Stage 135775 Expired
NCI E-021-1998-0-IT-12 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use IT EP 98961806.1 Expired
NCI E-021-1998-0-DE-10 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use DE EP 98961806.1 Expired
NCI E-021-1998-0-FR-11 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use FR EP 98961806.1 Expired
NCI E-021-1998-0-ES-13 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use ES EP 98961806.1 Expired
NCI E-021-1998-0-CH-09 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use CH EP 98961806.1 Expired
NCI E-021-1998-0-GB-14 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use GB EP 98961806.1 Expired
NCI E-021-1998-0-EP-05 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use EP National Stage 98961806.1 Expired
NCI E-021-1998-0-AU-03 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use AU National Stage 17041/99 Expired
NCI E-021-1998-0-PCT-02 Antibodies, Including Fv Molecules, and Immunoconjugates Having High Binding Affinity for Mesothelin and Methods for Their Use PCT PCT PCT/US1998/025270 Expired
NIAID E-282-1998-0-US-01 Antagonists of the Alpha Epsilon Beta 7 Integrin as Therapeutic Agents for Inflammatory Diseases US 60/109,957 Abandoned
CIT E-042-1997-0-PCT-02 SYSTEM AND METHOD FOR INTELLIGENT QUALITY CONTROL OF A PROCESS PCT PCT PCT/US1998/025182 Expired
NCI E-192-1997-0-CA-04 TRANSCRIPTION FACTOR DECOY AND TUMOR GROWTH INHIBITOR CA National Stage 2311182 Abandoned
NCI E-192-1997-0-AU-03 TRANSCRIPTION FACTOR DECOY AND TUMOR GROWTH INHIBI AU National Stage 16098/99 Abandoned
NCI E-219-1995-0-US-02 ALTERNATIVE OPEN READING FRAME DNA OF A NORMAL GENE AND A NOVEL HUMAN CANCER ANTIGEN ENCODED THEREIN US DIV 09/197,816 6087110 Expired PDF
NCI E-192-1997-0-PCT-02 TRANSCRIPTION FACTOR DECOY AND TUMOR GROWTH INHIBITOR PCT PCT PCT/US1998/025307 Expired
NCI E-192-1997-0-EP-05 TRANSCRIPTION FACTOR DECOY AND TUMOR GROWTH INHIBITORf EP National Stage 98960516.7 Abandoned
NCI E-223-1998-0-US-01 P53 and VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells US 60/109,563 Abandoned
NIAID E-144-1997-0-US-02 METHODS OF USING CR3 AND CR4 LIGANDS FOR INHIBITING INTERLEUKIN-12 TO TREAT AUTOIMMUNE DISEASE US ORD 09/196,867 Abandoned